NYSE: LLY

Eli Lilly and Company

Healthcare | Drug Manufacturers - General

Market prices for LLY are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$29.80

Eli Lilly and Company (NYSE: LLY) is a drug manufacturer. Figures from SEC EDGAR; updated 2026-10-18 12:34 UTC.

What Eli Lilly and Company does

Eli Lilly and Company, incorporated in 1901, is a pharmaceutical manufacturer that discovers, develops, and markets human pharmaceutical products globally. The company operates manufacturing and distribution facilities in the United States, Puerto Rico, Europe, and Asia, selling products in approximately 90 countries. Lilly's product portfolio spans multiple therapeutic areas, including cardiometabolic health treatments such as various insulin formulations and newer diabetes medications, as well as obesity and cardiovascular disease treatments.

Summarized from Eli Lilly and Company’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation	10-Q 2026-08-05
EPS (TTM)	$29.80
Return on equity	77.78%
Debt/equity	1.62

Revenue Trend

Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-22

2026-09-22DirectorAward4$5.0K
2026-09-22DirectorAward10$12.4K
2026-09-22DirectorAward8$9.9K

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

LILLY ENDOWMENT INC90,376,978$108.40B-1.6%
BlackRock, Inc.67,540,400$81.01B+2.2%
VANGUARD CAPITAL MANAGEMENT LLC53,528,868$64.20B+0.3%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2024-11-19Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-09-09Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-07-10Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

The EU’s Drug Regulator Backed Eli Lilly’s Weight-Loss Pill. Here’s What Foundayo Has to Show on October 29
Yahoo2026-10-17NEG
What Was Eli Lilly Telling You Before Its Stock Ran?
Yahoo2026-10-17
Lilly, Pfizer, J&J among winners of EU drug recommendations this month
Seeking Alpha Markets2026-10-16
Lilly wins EU backing for Foundayo weight-loss pill
Seeking Alpha Markets2026-10-16NEG
Eli Lilly's Biggest Shareholder Is Selling $347 Million of Stock. Should You Sell Too?
Yahoo2026-10-16

Questions this page answers

What does Eli Lilly and Company do?

Eli Lilly and Company, incorporated in 1901, is a pharmaceutical manufacturer that discovers, develops, and markets human pharmaceutical products globally.

When did LLY last file with the SEC?

Eli Lilly and Company's most recent SEC filing on record is a 10-Q filed 2026-08-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 12:34 UTC. This page is also available as JSON at /api/data?ticker=LLY and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LLY and 5,000+ tickers.

Create a free account — keep LLY

For your agent

GET /api/data?ticker=LLY

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt